Literature DB >> 3971922

Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas.

R A Huseby, M J Soares, F Talamantes.   

Abstract

Some endocrinological consequences of grafting hypophyses of mice to sites distant from the hypothalamic-pituitary portal vessels were investigated. Serum PRL levels in recipients rose within 3 weeks to levels seen during pregnancy, resulting in a premature increase in serum progesterone (P) levels. After 7 weeks, luteolytic effects were evident in BALB/c females, and P values had plateaued in the range of those seen in normal adult animals, while in BALB/c X C3H F1 hybrids, this effect was delayed, and P values rose, reaching, in some animals, levels reported during pregnancy. Despite continuing hyperprolactinemia, the fertility of graft-bearing females was reduced only slightly. By the 6th month, lesions of adenomyosis were frequent in uteri of C3H and F1 hybrids, but essentially absent from BALB/c animals. The number of corpora lutea was reduced in all experimental groups, yet serum P values were somewhat elevated in hybrid females and BALB/c animals bearing three grafts. Evidence is presented indicating that PRL enhances the action of P on both the estrogen-stimulating vagina and uterus. Small groups of grafted BALB/c and hybrid females not infected with exogenous mouse mammary tumor virus were allowed to survive until mammary cancers developed or until they reached 18 months of age. The grafts in the hybrids routinely became adenomatous, producing serm PRL levels of 1-21 X 10(3) ng/ml; only one secreted excessive GH. Adenomyosis wained in the aged hybrids, apparently due to declining ovarian function. The majority of the animals developed adenoid cystic mammary cancers that seemed to arise from areas of hyperplasia within dilated ducts rather than from alveolar hyperplasias, as is most frequently the case in mice carrying exogenous mouse mammary tumor virus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971922     DOI: 10.1210/endo-116-4-1440

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Hormonal control of alveolar development and its implications for breast carcinogenesis.

Authors:  Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  Effects of prolactin on gametes and zygotes during in vitro fertilization in mice.

Authors:  A Fukuda; Y Noda; T Mori; C Mori; H Hashimoto; K Hoshino
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

3.  Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

Authors:  H Wennbo; M Gebre-Medhin; A Gritli-Linde; C Ohlsson; O G Isaksson; J Törnell
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.

Authors:  Kathleen A O'Leary; Michael P Shea; Linda A Schuler
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Use of a murine endometriosis interna model for the characterization of compounds that effectively treat human endometriosis.

Authors:  Christiane Otto; Jenny Schkoldow; Elisabeth Krahl; Iris Fuchs; Hannes-Friedrich Ulbrich
Journal:  Exp Ther Med       Date:  2011-12-20       Impact factor: 2.447

6.  Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.

Authors:  Teresa A Rose-Hellekant; Lisa M Arendt; Matthew D Schroeder; Kennedy Gilchrist; Eric P Sandgren; Linda A Schuler
Journal:  Oncogene       Date:  2003-07-24       Impact factor: 9.867

Review 7.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

8.  Animal Models of Adenomyosis.

Authors:  Ryan M Marquardt; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  Semin Reprod Med       Date:  2020-10-26       Impact factor: 1.303

9.  Anterior pituitary gland modulates the release of atrial natriuretic peptides from cardiac atria.

Authors:  N Zamir; M Haass; J R Dave; Z Zukowska-Grojec
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

10.  Oxytocin receptor induces mammary tumorigenesis through prolactin/p-STAT5 pathway.

Authors:  Dan Li; Mingjun San; Jing Zhang; Anlan Yang; Wanhua Xie; Yang Chen; Xiaodan Lu; Yuntao Zhang; Mingyue Zhao; Xuechao Feng; Yaowu Zheng
Journal:  Cell Death Dis       Date:  2021-06-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.